Current Appointments & Affiliations
Assistant Professor of Medicine
·
2023 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2023 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable Non-Small Cell Lung Cancer: Updates and Future Perspectives
Journal Article Cancers · June 21, 2025 Historically, systemic therapy for resectable non-small cell lung cancer (NSCLC) has been associated with a modest impact on overall survival. The current treatment options for early-stage resectable NSCLC include neoadjuvant, adjuvant, and periope ... Full text CiteA Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC.
Journal Article Cancers (Basel) · May 30, 2025 The current standard of care for inoperable stage III non-small cell lung cancer (NSCLC) is concurrent chemotherapy and radiation therapy with consolidation durvalumab. Despite this approach, about 50% of patients will experience disease recurrence, with a ... Full text Link to item CiteRecent Grants
Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inhibitors
Clinical TrialPrincipal Investigator · Awarded by OncoC4 · 2025 - 2029Investigating the impact of intratumoral PCSK9 on antigen presentation in NSCLC
ResearchPrincipal Investigator · Awarded by Lung Cancer Initiative of North Carolina · 2025 - 2026Phase Ib Study of MEM-288 Oncolytic Virus in Combination with Nivolumab in Non-Small Cell Lung Cancer (NSCLC)
ResearchPrincipal Investigator · Awarded by Bristol-Myers Squibb Foundation · 2023 - 2026View All Grants
Education, Training & Certifications
Rostov State Medical University (Russia) ·
2009
M.D.